|
|
Volumn 36, Issue 1, 2000, Pages 310-325
|
|
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARDIAC AGENT;
EPTIFIBATIDE;
ESTROGEN;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FONDAPARINUX;
LAMIFIBAN;
LOW MOLECULAR WEIGHT HEPARIN;
MILRINONE;
PENTASACCHARIDE;
RECOMBINANT FIBROBLAST GROWTH FACTOR;
ROXITHROMYCIN;
SIBRAFIBAN;
SOTALOL;
STRONTIUM 90;
YTTRIUM 90;
ANGINA PECTORIS;
ANGIOCARDIOGRAPHY;
ARTICLE;
ATHEROSCLEROSIS;
BETA RADIATION;
BLOOD CLOT LYSIS;
BYPASS SURGERY;
CARDIOLOGY;
CARDIOVERSION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY;
CORONARY ARTERY DILATATION;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DOSE RESPONSE;
GAMMA RADIATION;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HEART SURGERY;
HEART VALVE REPLACEMENT;
HORMONAL THERAPY;
HOSPITALIZATION;
HUMAN;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
PRIORITY JOURNAL;
RESTENOSIS;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNITED STATES;
ANGINA PECTORIS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
FIBRINOLYTIC AGENTS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
SAFETY;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0033926259
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(00)00805-6 Document Type: Article |
|
Times cited : (72)
|
|
References (0)
|